BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.38 EUR | -0.73% |
|
+1.18% | -15.60% |
| Jun. 06 | Bayer: working with PAPACKS on sustainable packaging | CF |
| Jun. 06 | BAYER AG : DZ Bank maintains a Buy rating | ZD |
| Sales 2024 * | 47.12B 51.32B | Sales 2025 * | 47.9B 52.18B | Capitalization | 27.89B 30.37B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.33B 2.54B | Net income 2025 * | 3.18B 3.46B | EV / Sales 2024 * | 1.3 x |
| Net Debt 2024 * | 33.35B 36.32B | Net Debt 2025 * | 30.49B 33.21B | EV / Sales 2025 * | 1.22 x |
| P/E ratio 2024 * |
12.4
x | P/E ratio 2025 * |
8.71
x | Employees | 98,189 |
| Yield 2024 * |
0.39% | Yield 2025 * |
0.77% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
More news
| 1 day | -0.73% | ||
| 1 week | +5.42% | ||
| Current month | +0.51% | ||
| 1 month | +1.30% | ||
| 3 months | +9.36% | ||
| 6 months | -10.47% | ||
| Current year | -15.60% |
1 week
27.86
29.29
1 month
26.9230.41
Current year
24.9636.09
1 year
24.9653.80
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 23-03-31 |
| Director of Finance/CFO | 55 | 18-04-25 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 17-03-31 |
Alberto Weisser
BRD | Director/Board Member | 68 | 21-03-31 |
Paul Achleitner
BRD | Director/Board Member | 67 | 02-03-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-06 | 28.38 | -0.73% | 2,690,304 |
| 24-06-05 | 28.6 | +0.92% | 3,985,730 |
| 24-06-04 | 28.34 | -1.01% | 3,399,279 |
| 24-06-03 | 28.62 | +1.36% | 2,552,917 |
| 24-05-31 | 28.24 | +0.66% | 5,104,857 |
Delayed Quote Xetra, June 06, 2024 at 11:35 am EDT
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
2024-08-06
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.38
EUR
Average target price
36.64
EUR
Spread / Average Target
+29.07%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.60% | 30.53B | |
| +43.64% | 749B | |
| +39.42% | 605B | |
| -6.58% | 351B | |
| +19.72% | 328B | |
| +8.78% | 292B | |
| +11.92% | 216B | |
| -2.62% | 214B | |
| +0.03% | 167B | |
| +6.13% | 165B |
- Stock Market
- Equities
- BAYN Stock
